Maraviroc (CCR5) Antagonism to Decrease the Incidence of the Immune Reconstitution Inflammatory Syndrome in HIV-Infected Patients

NCT00988780 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

276

Enrollment

OTHER

Sponsor class

Conditions

Immune Reconstitution Inflammatory Syndrome
HIV
HIV Infections

Interventions

DRUG: maraviroc
DRUG: Placebo

Sponsor

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]